Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032
Overview
The Middle East & Africa Medication Assisted Therapy (MAT) Market is expected to reach a 715.01 by 2032 and is projected to grow at a CAGR of 10.97% from 2025 to 2032.
Revenue, 2024 ()
414.18
Forecast, 2032 ()
715.01
CAGR, 2024 - 2032
10.97%
Report Coverage
Middle East & Africa
Middle East & Africa Medication Assisted Therapy (MAT) Market 2018-2032
Middle East & Africa Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 414.18
- Projected Market Size (2032): 715.01
- CAGR (2025-2032): 10.97%
Key Findings of Middle East & Africa Medication Assisted Therapy (MAT) Market
- The Middle East & Africa Medication Assisted Therapy (MAT) Market was valued at 414.18 in 2024.
- The Middle East & Africa Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 10.97% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 391.35
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 13.57% during the forecast period from 2024 to 2032.
Middle East & Africa Medication Assisted Therapy (MAT) Market Scope
Middle East & Africa Medication Assisted Therapy (MAT) Market Segmentation & Scope
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Route of Administration
- Others
- Parenteral
- Oral
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Type
- Therapy
- Medication
Middle East & Africa Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 414.18 |
| Market Value in 2032 | 715.01 |
| CAGR (2025-2032) | 10.97% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Population Type,End User,Route of Administration,Distribution Channel,Products,Drug Type,Dosage Form,Type |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 414.18 in 2024
- Key Country: South Africa, leading in terms of revenue with value of 128.91 in 2024.
Segments and Scope
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 391.35 in the year 2024.
- Adults is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.07 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 202.42 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.73 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 129.70 in the year 2024.
- Oral is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.38 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 130.21 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.57 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 50.74 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 13.57 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 210.00 in the year 2024.
- Generics is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.82 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 137.82 in the year 2024.
- Immediate Release is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.27 % in forecast period 2025-2032.
-
Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 223.87 in the year 2024.
- Medication is the Fastest growing segment in Middle East & Africa Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.71 % in forecast period 2025-2032.
Middle East & Africa Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
Middle East & Africa Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
Middle East & Africa Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Population Type,End User,Route of Administration,Distribution Channel,Products,Drug Type,Dosage Form,Type.
Middle East & Africa Medication Assisted Therapy (MAT) Market was valued at USD 414.18(Revenue in ) in 2020.
Middle East & Africa Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 10.97% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Middle East & Africa Medication Assisted Therapy (MAT) Market, holding a largest market share of 391.35 in 2024
Coming Soon....
Middle East & Africa Medication Assisted Therapy (MAT) Market Scope
Middle East & Africa Medication Assisted Therapy (MAT) Market Segmentation & Scope
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Route of Administration
- Others
- Parenteral
- Oral
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Type
- Therapy
- Medication
Frequently Asked Questions
The Middle East & Africa Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Population Type,End User,Route of Administration,Distribution Channel,Products,Drug Type,Dosage Form,Type.
Middle East & Africa Medication Assisted Therapy (MAT) Market was valued at USD 414.18(Revenue in ) in 2020.
Middle East & Africa Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 10.97% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Medication Assisted Therapy (MAT) Market for final year is USD 715.01 ().
Middle East & Africa Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Population Type,End User,Route of Administration,Distribution Channel,Products,Drug Type,Dosage Form,Type.
Middle East & Africa Medication Assisted Therapy (MAT) Market was valued at USD 414.18(Revenue in ) in 2020.
Middle East & Africa Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 10.97% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Medication Assisted Therapy (MAT) Market for final year is USD 715.01 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.